Maravai Lifesciences Holdings (MRVI) Income from Non-Controlling Interests (2020 - 2026)

Maravai Lifesciences Holdings (MRVI) recorded quarterly Income from Non-Controlling Interests of -$2.6 million in Q1 2026, up 90.33% quarter-over-quarter from -$27.3 million in Q4 2025, and up 88.46% on a YoY basis from -$1.4 million in Q1 2025.

Maravai Lifesciences Holdings (MRVI) Income from Non-Controlling Interests (2020 - 2026) Analysis & Trends

Maravai Lifesciences Holdings' Income from Non-Controlling Interests history runs 7 years deep, the most recent figure standing at -$2.6 million for Q1 2026.

  • In Q1 2026, Income from Non-Controlling Interests rose 88.46% year-over-year to -$2.6 million; the TTM figure through Mar 2026 stood at -$79.7 million (up 37.26% YoY), while the FY2025 annual figure was -$100.0 million, up 12.88% from the prior year.
  • Income from Non-Controlling Interests was -$2.6 million for Q1 2026 at Maravai Lifesciences Holdings, up from -$27.3 million in the prior quarter.
  • In the past five years, Income from Non-Controlling Interests ranged from a high of $85.5 million in Q2 2022 to a low of -$75.4 million in Q3 2024.
  • Historically, Income from Non-Controlling Interests has averaged $2.0 million across 5 years, with a median of -$8.6 million in 2024.
  • The sharpest annual moves came in 2024 and 2026: Income from Non-Controlling Interests tumbled 772.47% in 2024, then surged 88.46% in 2026.
  • A 5-year view of Income from Non-Controlling Interests shows it stood at $49.8 million in 2022, then sank by 108.08% to -$4.0 million in 2023, then plunged by 401.17% to -$20.2 million in 2024, then sank by 35.57% to -$27.3 million in 2025, then soared by 90.33% to -$2.6 million in 2026.
  • The last three Income from Non-Controlling Interests figures came in at -$2.6 million (Q1 2026), -$27.3 million (Q4 2025), and -$19.5 million (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Inc. Minority (Qtr)
1 Alterity Therapeutics 762,369.55 Bn 762,369.51 Bn - -
2 Belite Bio 55,096.00 Bn 55,096.00 Bn - -
3 Quantum Biopharma 17,755.80 Bn 17,755.79 Bn - -13.75 Mn
4 Legend Biotech 3,486.00 Bn 3,485.71 Bn 242.10 Mn -
5 Akari Therapeutics 1,737.42 Bn 1,737.41 Bn - -
6 Evaxion A 1,551.28 Bn 1,551.26 Bn - -
7 Psyence Biomedical 227.32 Bn 227.31 Bn - -
8 Vertex Pharmaceuticals 110.84 Bn 103.59 Bn 2.59 Bn -
9 Abivax 91.71 Bn 91.71 Bn - -
10 Maravai Lifesciences Holdings 743.11 Mn 734.71 Mn 33.70 Mn -2.64 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 -2.64 Mn
Dec 31, 2025 -27.33 Mn
Sep 30, 2025 -19.50 Mn
Jun 30, 2025 -30.25 Mn
Mar 31, 2025 -22.91 Mn
Dec 31, 2024 -20.16 Mn
Sep 30, 2024 -75.38 Mn
Jun 30, 2024 -8.63 Mn
Mar 31, 2024 -10.60 Mn
Dec 31, 2023 -4.02 Mn
Sep 30, 2023 -8.64 Mn
Jun 30, 2023 -5.40 Mn
Mar 31, 2023 -1.28 Mn
Dec 31, 2022 49.80 Mn
Sep 30, 2022 55.18 Mn
Jun 30, 2022 85.48 Mn
Mar 31, 2022 80.00 Mn
Dec 31, 2021 71.28 Mn
Sep 30, 2021 78.22 Mn
Jun 30, 2021 85.35 Mn